Advanced Magnetics, Inc.
Nanobiotech company reports loss of $0.07 per share
Published in Pharma Investments, Ventures and Law Weekly, May 16th, 2004
Revenues for the quarter were $766,530 as compared to revenues of $1,013,948 for the same period in fiscal 2003. There was a net loss of $566,001, or $0.07 per share, as compared to a net loss of $647,518, or $0.10 per share, for the second fiscal quarter of 2003. The decrease in revenues for the quarter ended March 31, 2004, is partly the result of a decrease in the recognition of deferred license fee revenue from a license and marketing agreement covering Combidex(C).
As a result of fluctuations in...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly
More Articles from Pharma Investments, Ventures and Law Weekly
- Abiomed, Inc.
Option grant to new CEO reported under NASDAQ marketplace rule - Affymax, Inc.
Peptide drug maker completes Series C financing, adds new board member - Agentase, LLC
Biocatalyst maker receives $100,000 investment - Aksys, Ltd.
Dialysis systems developer files registration statement with SEC - AngioGenex, Inc.
Oncology company completes bridge financing - Avanir Pharmaceuticals
Pharmaceutical company files shelf registration statement - More from this issue of Pharma Investments, Ventures and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
